Rivaroxaban
Abstract
Reactions 1704, p335 - 2 Jun 2018 Hepatitis and synthetic liver failure: case report A 39-year-old woman developed hepatitis and synthetic liver failure during treatment with rivaroxaban for deep vein thrombosis (DVT). The woman was commenced on rivaroxaban 20mg daily [route not stated] for deep vein thrombosis of the left peroneus, and developed hepatitis and synthetic liver failure. Her liver function tests were markedly deranged at a clinical review 4 months following the initiation of...